BREAKING NEWS  – Rapid detection of antibiotic resistance in down to 2 hours on primary clinical sample – BREAKING NEWS 

December 2023 – Capital increase

A new fundraising round has been opened and will close in Q1 2024, with existing and new investors. This round will allow us to speed up the finalization of our first IVD product.

March 2023 – ORSET Family office and PULSALYS join Molsid

We are pleased to announce that the Savoyard (French) Family Office “ORSET Group” has entered our capital, as well as the Lyon based Technology transfer agency “PULSALYS”. The fundraising round has been finalized in March 2023.

Inside Molsid

Get what you are screening for: some more information about who we are and what we do. Molsid’s first corporate video is online, enjoy!   Molsid corporate video